Zhigong Wei

机构：North Sichuan Medical University, Sichuan University, West China Medical Center of Sichuan University, Sichuan Agricultural University, First Affiliated Hospital of Sichuan Medical University, West China Hospital of Sichuan University, Sichuan Cancer Hospital · ORCID：0000-0001-8112-9508

发表论文 69 篇 · 总被引 581 次 · h-index 13

代表论文

• The PI3K/Akt/mTOR Pathway: Immuno-Metabolic Orchestration in IR/MASH-Associated Hepatocellular Carcinoma (2025 · International Journal of Biological Sciences · 被引 21)
• Association between sedentary behavior, depressive symptoms, and the risk of all-cause and cause-specific mortality among U.S. cancer survivors (2025 · BMC Cancer · 被引 6)
• Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors (2025 · Cancer Immunology Immunotherapy · 被引 6)
• Radio-Activable Gold-Single-Atom-Based Artificial Enzymes with Cascade Biocatalysis and Enhanced Radiosensitization to Prevent Metastasis and Recurrence in Malignancies (2026 · Journal of the American Chemical Society · 被引 4)
• Causal effect of gut microbiota on occurrence of herpes zoster and postherpetic neuralgia, and role of Tyzzerella 3 (2024 · European journal of medical research · 被引 3)
• Harnessing the Systemic Immunoinflammatory Index as a Potential Predictive Tool for Recurrent or Metastatic Nasopharyngeal Carcinoma Undergoing PD-L1 Inhibitor (2024 · Journal of Inflammation Research · 被引 2)